Faculty profile
Bernard Jasmin
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Ottawa directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $956,250
Characterizing the implication and therapeutic potential of AMPK signaling in Myotonic Dystrophy Type 1 (DM1)
CIHR · 2026 · Nominated PI
- $100,000
Characterizing the implication and therapeutic potential of AMPK signaling in Myotonic Dystrophy Type 1 (DM1)
CIHR · 2025 · Nominated PI
- $1,000,000
NMD4C: the neuromuscular network for Canada
CIHR · 2023 · Co-investigator
Characterizing the implication and therapeutic potential of AMPK signaling in Myotonic Dystrophy Type 1 (DM1)
Principal investigators: Jasmin, Bernard J
Keywords: Alternative Splicing; Ampk Signalling; Excercise; Myotonic Dystrophy Type 1; Neuromuscular Disease; Pharmacological; Preclinical; Rna-Binding Proteins; Skeletal Muscle; Therapeutics
Characterizing the implication and therapeutic potential of AMPK signaling in Myotonic Dystrophy Type 1 (DM1)
Principal investigators: Jasmin, Bernard J
Keywords: Alternative Splicing; Ampk Signalling; Exercise; Myotonic Dystrophy Type 1; Neuromuscular Disease; Pharmacological; Preclinical; Rna Binding Proteins; Skeletal Muscle; Therapeutic
NMD4C: the neuromuscular network for Canada
Principal investigators: Lochmüller, Hanns; Osman, Homira; Brais, Bernard; Campbell, Craig Gordon N; Chang, Natasha C; Dowling, James; Gagnon, Cynthia; Gonorazky, Hernan D; Hodgkinson, Victoria; Karamchandani, Jason; Korngut, Lawrence W; Kothary, Rashmi K; Mah, Jean K; O'Connell, Colleen; Patten, Kessen; Rossi, Fabio M; Schellenberg, Kerri; Selby, Kathryn A; Warman Chardon, Jodi
Keywords: Clinical Trial Networks; Networks; Neuromuscular Disease; Open Science; Patient Partnerships; Preclinical Research Resources; Training And Education; Translational Research
The role of Pannexin 1 in Skeletal Muscle Regeneration and Duchenne Muscular Dystrophy
Principal investigators: Cowan, Kyle
Keywords: Duchenne Muscular Dystrophy; Muscle Regeneration; Pannexin 1; Satellite Cell; Skeletal Muscle
6th Ottawa International Conference on Neuromuscular Disease and Biology
Principal investigators: Parks, Robin J
Keywords: Als; Conference; Dystrophinopathies; Genetic Disease; Motor Neuron; Muscle; Myopathies; Neuromuscular; Neuropathies; Stem Cells
The role of Pannexin 1 in Skeletal Muscle Regeneration and Duchenne Muscular Dystrophy
Principal investigators: Cowan, Kyle
Keywords: Duchenne Muscular Dystrophy; Muscle Regeneration; Pannexin 1; Satellite Cell; Skeletal Muscle
5th Ottawa International Conference on Neuromuscular Disease and Biology
Principal investigators: Parks, Robin J
Keywords: Als; Conference; Dystrophinopathies; Motor Neuron; Muscle; Myopathies; Neuromuscular; Neuron; Neuropathies; Stem Cells
Pharmacologic and RNAi Screens for Myotonic Dystrophy Type 1 foci modulators; towards Novel DM1 therapeutic approaches
Principal investigators: Mackenzie, Alexander E; Jasmin, Bernard J
Keywords: Cell Phenotype; Drug Screen; Muscular Dystrophy
Investigating the RNA-binding protein HuD and CARM1 as novel therapeutic targets for Spinal Muscular Atrophy
Principal investigators: Côté, Jocelyn
Keywords: Arginine Methylation; Autophagy; Combinatorial Therapies; Gene Therapy; Local Translation; Motor Neurons; Post-Transcriptional Regulation Of Gene Expression; Rna Transport Granules; Rna-Binding Proteins; Spinal Muscular Atrophy
Recognition and Validation of Druggable Targets from the Response to Cognitive Behaviour Therapy in Myotonic Dystrophy type 1 patients from Integrated -Omics Networks
Principal investigators: Mackenzie, Alexander E
Keywords: Cognitive Behavioural Therapy (Cbt); Myotonic Dystrophy Type 1 (Dm1); Systems Biology
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.